CVS Health Corp
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management… Read more
CVS Health Corp (CVS) - Net Assets
Latest net assets as of December 2025: $75.38 Billion USD
Based on the latest financial reports, CVS Health Corp (CVS) has net assets worth $75.38 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($261.06 Billion) and total liabilities ($185.68 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $75.38 Billion |
| % of Total Assets | 28.87% |
| Annual Growth Rate | 11.14% |
| 5-Year Change | N/A |
| 10-Year Change | 104.65% |
| Growth Volatility | 34.77 |
CVS Health Corp - Net Assets Trend (1985–2025)
This chart illustrates how CVS Health Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CVS Health Corp (1985–2025)
The table below shows the annual net assets of CVS Health Corp from 1985 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $75.38 Billion | -0.46% |
| 2024-12-31 | $75.73 Billion | -1.18% |
| 2023-12-31 | $76.64 Billion | +6.78% |
| 2022-12-31 | $71.77 Billion | -4.79% |
| 2021-12-31 | $75.38 Billion | +8.15% |
| 2020-12-31 | $69.70 Billion | +8.62% |
| 2019-12-31 | $64.17 Billion | +9.61% |
| 2018-12-31 | $58.54 Billion | +55.31% |
| 2017-12-31 | $37.70 Billion | +2.34% |
| 2016-12-31 | $36.83 Billion | -0.99% |
| 2015-12-31 | $37.20 Billion | -2.00% |
| 2014-12-31 | $37.96 Billion | +0.07% |
| 2013-12-31 | $37.94 Billion | +0.76% |
| 2012-12-31 | $37.65 Billion | -1.05% |
| 2011-12-31 | $38.05 Billion | +0.84% |
| 2010-12-31 | $37.73 Billion | +5.50% |
| 2009-12-31 | $35.77 Billion | +3.45% |
| 2008-12-31 | $34.57 Billion | +10.38% |
| 2007-12-31 | $31.32 Billion | +215.82% |
| 2006-12-31 | $9.92 Billion | +19.04% |
| 2005-12-31 | $8.33 Billion | +19.24% |
| 2004-12-31 | $6.99 Billion | +16.03% |
| 2003-12-31 | $6.02 Billion | +15.87% |
| 2002-12-31 | $5.20 Billion | +13.80% |
| 2001-12-31 | $4.57 Billion | +6.09% |
| 2000-12-31 | $4.30 Billion | +16.98% |
| 1999-12-31 | $3.68 Billion | +18.28% |
| 1998-12-31 | $3.11 Billion | +18.99% |
| 1997-12-31 | $2.61 Billion | +19.04% |
| 1996-12-31 | $2.20 Billion | +33.69% |
| 1995-12-31 | $1.64 Billion | -34.06% |
| 1994-12-31 | $2.49 Billion | +6.38% |
| 1993-12-31 | $2.34 Billion | +7.53% |
| 1992-12-31 | $2.18 Billion | -0.86% |
| 1991-12-31 | $2.20 Billion | +12.16% |
| 1990-12-31 | $1.96 Billion | +13.80% |
| 1989-12-31 | $1.72 Billion | +0.88% |
| 1988-12-31 | $1.71 Billion | +16.98% |
| 1987-12-31 | $1.46 Billion | +15.49% |
| 1986-12-31 | $1.26 Billion | +14.59% |
| 1985-12-31 | $1.10 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to CVS Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5930.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $61.20 Billion | 81.36% |
| Common Stock | $18.00 Million | 0.02% |
| Other Comprehensive Income | $406.00 Million | 0.54% |
| Other Components | $13.59 Billion | 18.07% |
| Total Equity | $75.21 Billion | 100.00% |
CVS Health Corp Competitors by Market Cap
The table below lists competitors of CVS Health Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rio Tinto Group
PINK:RTNTF
|
$97.13 Billion |
|
China Shenhua Energy Co Ltd
PINK:CSUAY
|
$97.80 Billion |
|
China Merchants Bank Co Ltd Class H
PINK:CIHHF
|
$97.81 Billion |
|
CNOOC Limited
SHG:600938
|
$97.85 Billion |
|
Western Digital Corporation
NASDAQ:WDC
|
$96.27 Billion |
|
Duke Energy Corporation
NYSE:DUK
|
$96.16 Billion |
|
Howmet Aerospace Inc
NYSE MKT:HWM
|
$95.77 Billion |
|
Xiaomi Corp
PINK:XIACF
|
$95.43 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CVS Health Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 75,560,000,000 to 75,214,000,000, a change of -346,000,000 (-0.5%).
- Net income of 1,768,000,000 contributed positively to equity growth.
- Dividend payments of 3,397,000,000 reduced retained earnings.
- Share repurchases of 394,000,000 reduced equity.
- Other comprehensive income increased equity by 526,000,000.
- Other factors increased equity by 1,151,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.77 Billion | +2.35% |
| Dividends Paid | $3.40 Billion | -4.52% |
| Share Repurchases | $394.00 Million | -0.52% |
| Other Comprehensive Income | $526.00 Million | +0.7% |
| Other Changes | $1.15 Billion | +1.53% |
| Total Change | $- | -0.46% |
Book Value vs Market Value Analysis
This analysis compares CVS Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 29.81x to 1.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $2.54 | $75.84 | x |
| 1986-12-31 | $2.92 | $75.84 | x |
| 1987-12-31 | $3.37 | $75.84 | x |
| 1988-12-31 | $3.92 | $75.84 | x |
| 1989-12-31 | $3.76 | $75.84 | x |
| 1990-12-31 | $4.52 | $75.84 | x |
| 1991-12-31 | $5.06 | $75.84 | x |
| 1992-12-31 | $4.94 | $75.84 | x |
| 1993-12-31 | $4.25 | $75.84 | x |
| 1994-12-31 | $5.64 | $75.84 | x |
| 1995-12-31 | $3.59 | $75.84 | x |
| 1996-12-31 | $5.15 | $75.84 | x |
| 1997-12-31 | $3.31 | $75.84 | x |
| 1998-12-31 | $3.84 | $75.84 | x |
| 1999-12-31 | $4.50 | $75.84 | x |
| 2000-12-31 | $5.39 | $75.84 | x |
| 2001-12-31 | $5.73 | $75.84 | x |
| 2002-12-31 | $6.41 | $75.84 | x |
| 2003-12-31 | $7.45 | $75.84 | x |
| 2004-12-31 | $8.50 | $75.84 | x |
| 2005-12-31 | $9.90 | $75.84 | x |
| 2006-12-31 | $11.62 | $75.84 | x |
| 2007-12-31 | $22.83 | $75.84 | x |
| 2008-12-31 | $23.54 | $75.84 | x |
| 2009-12-31 | $24.67 | $75.84 | x |
| 2010-12-31 | $27.38 | $75.84 | x |
| 2011-12-31 | $28.25 | $75.84 | x |
| 2012-12-31 | $29.42 | $75.84 | x |
| 2013-12-31 | $30.94 | $75.84 | x |
| 2014-12-31 | $32.47 | $75.84 | x |
| 2015-12-31 | $33.03 | $75.84 | x |
| 2016-12-31 | $34.13 | $75.84 | x |
| 2017-12-31 | $36.81 | $75.84 | x |
| 2018-12-31 | $55.77 | $75.84 | x |
| 2019-12-31 | $48.94 | $75.84 | x |
| 2020-12-31 | $52.81 | $75.84 | x |
| 2021-12-31 | $56.49 | $75.84 | x |
| 2022-12-31 | $54.02 | $75.84 | x |
| 2023-12-31 | $59.27 | $75.84 | x |
| 2024-12-31 | $59.87 | $75.84 | x |
| 2025-12-31 | $59.18 | $75.84 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CVS Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.44%
- • Asset Turnover: 1.54x
- • Equity Multiplier: 3.47x
- Recent ROE (2.35%) is below the historical average (11.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 19.07% | 4.40% | 2.64x | 1.64x | $99.98 Million |
| 1986 | 18.87% | 4.53% | 2.63x | 1.58x | $112.00 Million |
| 1987 | 19.57% | 4.81% | 2.66x | 1.53x | $139.54 Million |
| 1988 | 20.78% | 5.23% | 2.48x | 1.60x | $183.87 Million |
| 1989 | 24.57% | 5.27% | 2.49x | 1.87x | $236.10 Million |
| 1990 | 20.79% | 4.44% | 2.37x | 1.98x | $199.94 Million |
| 1991 | 16.58% | 3.51% | 2.42x | 1.95x | $137.54 Million |
| 1992 | 6.42% | 1.28% | 2.48x | 2.03x | $-74.39 Million |
| 1993 | 14.76% | 3.18% | 2.44x | 1.90x | $106.98 Million |
| 1994 | 12.90% | 2.72% | 2.38x | 1.99x | $69.21 Million |
| 1995 | -36.98% | -5.87% | 2.46x | 2.56x | $-727.71 Million |
| 1996 | 9.48% | 1.76% | 2.08x | 2.59x | $-11.44 Million |
| 1997 | 3.40% | 0.65% | 2.30x | 2.29x | $-172.66 Million |
| 1998 | 12.36% | 2.52% | 2.28x | 2.15x | $73.40 Million |
| 1999 | 17.26% | 3.51% | 2.49x | 1.98x | $267.13 Million |
| 2000 | 17.33% | 3.71% | 2.53x | 1.85x | $315.54 Million |
| 2001 | 9.05% | 1.86% | 2.58x | 1.89x | $-43.49 Million |
| 2002 | 13.79% | 2.96% | 2.51x | 1.86x | $196.90 Million |
| 2003 | 14.07% | 3.19% | 2.52x | 1.75x | $245.12 Million |
| 2004 | 13.15% | 3.00% | 2.10x | 2.08x | $220.08 Million |
| 2005 | 14.70% | 3.31% | 2.42x | 1.83x | $391.58 Million |
| 2006 | 13.80% | 3.12% | 2.13x | 2.07x | $377.14 Million |
| 2007 | 8.42% | 3.45% | 1.39x | 1.75x | $-495.19 Million |
| 2008 | 9.29% | 3.67% | 1.43x | 1.76x | $-245.40 Million |
| 2009 | 10.33% | 3.76% | 1.59x | 1.72x | $119.20 Million |
| 2010 | 9.09% | 3.58% | 1.54x | 1.65x | $-343.00 Million |
| 2011 | 9.10% | 3.23% | 1.66x | 1.70x | $-343.10 Million |
| 2012 | 10.26% | 3.14% | 1.86x | 1.76x | $98.70 Million |
| 2013 | 12.10% | 3.62% | 1.77x | 1.89x | $798.20 Million |
| 2014 | 12.23% | 3.33% | 1.88x | 1.95x | $848.20 Million |
| 2015 | 14.08% | 3.42% | 1.66x | 2.49x | $1.52 Billion |
| 2016 | 14.44% | 2.99% | 1.88x | 2.56x | $1.63 Billion |
| 2017 | 17.57% | 3.58% | 1.94x | 2.52x | $2.85 Billion |
| 2018 | -1.02% | -0.31% | 0.99x | 3.37x | $-6.42 Billion |
| 2019 | 10.39% | 2.58% | 1.15x | 3.48x | $247.60 Million |
| 2020 | 10.35% | 2.67% | 1.16x | 3.32x | $240.10 Million |
| 2021 | 10.66% | 2.74% | 1.25x | 3.10x | $493.50 Million |
| 2022 | 6.03% | 1.34% | 1.41x | 3.19x | $-2.84 Billion |
| 2023 | 10.91% | 2.33% | 1.43x | 3.27x | $697.90 Million |
| 2024 | 6.11% | 1.24% | 1.47x | 3.35x | $-2.94 Billion |
| 2025 | 2.35% | 0.44% | 1.54x | 3.47x | $-5.75 Billion |
Industry Comparison
This section compares CVS Health Corp's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $9,160,983,612
- Average return on equity (ROE) among peers: -6.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CVS Health Corp (CVS) | $75.38 Billion | 19.07% | 2.46x | $96.29 Billion |
| Alignment Healthcare LLC (ALHC) | $239.30 Million | -62.49% | 1.65x | $2.97 Billion |
| Cigna Corp (CI) | $41.24 Billion | 8.33% | 2.78x | $72.47 Billion |
| Clover Health Investments Corp (CLOV) | $-17.63K | 0.00% | 0.00x | $805.21 Million |
| Centene Corp (CNC) | $326.42 Million | -13.37% | 1.74x | $17.01 Billion |
| CarePayment Technologies Inc (CPYT) | $6.95 Million | -32.50% | 0.49x | $2.47K |
| Elevance Health Inc (ELV) | $23.81 Billion | 12.12% | 1.15x | $63.54 Billion |
| Humana Inc (HUM) | $16.10 Billion | 18.21% | 1.75x | $20.40 Billion |
| Interact Holdings Group Inc (IHGP) | $-1.46 Million | 0.00% | 0.00x | $334.55 |
| Molina Healthcare Inc (MOH) | $719.06 Million | 7.64% | 1.10x | $6.97 Billion |